abstract |
The present invention relates to compounds of formula (I) in which the radical values are as defined hereinafter, which are applicable to the treatment of diseases and pathological conditions mediated by sodium-dependent rival D-glucose (SGLT), such as diabetes. The present invention also relates to methods of treating such diseases and pathological conditions and compositions, etc., intended for treatment. |